Essentials of Pharmaceutical Preformulation

Essentials of Pharmaceutical Preformulation

Volumn , Issue , 2012, Pages 1-252

  Gaisford, Simon ^a   Saunders, Mark ^b  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b Kuecept Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; DRUG PRODUCTS; STUDENTS;

COMPANION WEBSITE; INDUSTRIAL EXPERIENCE; MACROSCOPIC PROPERTIES; PHARMACEUTICAL DEVELOPMENT; PHARMACEUTICAL SCIENCE; PHARMACEUTICAL SECTOR; PRODUCT PERFORMANCE; UV SPECTROPHOTOMETRY;

MEDICINE;

EID: 84914105462     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118423226     Document Type: Book

References (165)

1. Ahuja, S. and Rasmussen, H. (2007) HPLC Method Development for Pharmaceuticals, Separation Science and Technology Series, vol. 8, Academic Press, London. ISBN 0-1237-0540-1.
2. Aubuchon, S.R. and Gill, P.S. (1997) The utility of phase correction in modulated DSC. J. Therm. Anal. Cal., 49, 1039-1044.
3. Burke, R.W. and Mavrodineanu, R. (1976) Acidic potassium dichromate solutions as ultraviolet absorbance standards. J. Res. Natl Bur. Stand. A, 80A, 631-636.
4. Burke, R.W. and Mavrodineanu, R. (1977) Standard reference materials: certification and use of acidic potassium dichromate solutions as an ultraviolet absorbance standard -SRM 935, NBS Special Publication 260-54.
5. Haines, P.J. (ed.) (2002) Principles of Thermal Analysis and Calorimetry, Royal Society of Chemistry, Cambridge. ISBN 0-8540-4610-0.
6. ICH Guideline Q2(R1) (2005) Validation of analytical procedures: text and methodology, International Conference on Harmonisation.
7. Paul, S.M., Mytelka, D.S., Dunwiddie, C.T. et al. (2010) How to improve R&D productivity: the pharmaceutical industry's grand challenge. Nat. Rev. Drug Disc., 9, 203-214.
8. Poole, C.F. and Dias, N.C. (2000) Practitioner's guide to method development in thinlayer chromatography. J. Chromatogr. A., 892, 123-142.
9. Reading, M., Luget, A. and Wilson, R. (1994) Modulated differential scanning calorimetry. Thermochim. Acta, 238, 295-307.
10. Reading, M., Craig, D.Q.M., Murphy, J.R. and Kett, V.L. (2007) Modulated temperature differential scanning calorimetry. In Thermal Analysis of Pharmaceuticals (eds D.Q.M. Craig and M. Reading), CRC Press, Boca Raton, FL. ISBN 0-8247-5814-5.
11. Weidner, V.R., Mavrodineanu, R., and Mielenz, K.D. (1985) Spectral transmittance characteristics of holmium oxide in perchloric acid solution. J. Res. Natl Bur. Stand., 90, 115-125.
12. Wells, J.I. (1988) Pharmaceutical Preformulation. The Physicochemical Properties of Drug Substances, John Wiley & Sons, Ltd, Chichester. ISBN 0-470-21114-8.
13. a distribution of drugs: application to drug discovery. Perspect. Med. Chem., 1, 25-38.
14. a values for pharmaceutical substances. In Profiles of Drug Substances, Excipients and Related Methodology (ed. H.B. Brittain), vol. 33, Academic Press, San Diego, pp. 1-726. ISBN 9780-1226-0833-9.
15. Shedlovsky, T. (1962) The behaviour of carboxylic acids in mixed solvents. In Electrolytes (ed. B. Pesce), Pergamon Press, pp. 146-151. ISBN 0-0801-3778-4.
16. a determination of water-insoluble compounds: validation study in methanol/water mixtures. Int. J. Pharm., 151, 235-248.
17. Wells, J.I. (1988) Pharmaceutical preformulation. In The Physicochemical Properties of Drug Substances, John Wiley & Sons, Ltd, Chichester. ISBN 0-470-21114-8.
18. Wu, Y. and Fassihi, R. (2005) Stability of metronidazole, tetracycline HCl and famotidine alone and in combination. Int. J. Pharm., 290, 1-13.
19. Yasuda, M. (1959) Dissociation constants of some carboxylic acids in mixed aqueous solvents. Bull. Chem. Soc. Jpn, 32, 429-432.
20. Beezer, A.E., Gooch, C.A., Hunter, W.H. and Volpe, P.L. (1987) A thermodynamic analysis of the Collander equation and establishment of a reference solvent for use in drug partitioning studies. J. Pharm. Pharmacol., 39, 774-779.
21. Biagi, G.L., Barbaro, A.M., Gamba, M.F. and Guerra, M.C. (1964) Partition data of penicillins determined by means of reversed-phase thin-layer chromatography. J. Chromatogr. A, 41, 371-379.
22. Biagi, G.L., Barbaro, A.M., Guerra, M.C. and Gamba, M.F. (1969) Partition data of cephalosporins determined by means of reversed-phase thin layer chromatography. J. Chromatogr. A, 44, 195-198.
23. Biagi, G.L., Barbaro, A.M., Sapone, A. and Recanatini, M. (1994a) Determination of lipophilicity by means of reversed-phase thin-layer chromatography. i. Basic aspects and relationship between slope and intercept of TLC equations. J. Chromatogr. A, 662, 341-361.
24. Biagi, G.L., Barbaro, A.M., Sapone, A. and Recanatini, M. (1994b) Determination of lipophilicity by means of reversed-phase thin-layer chromatography. ii. Influence of the organic modifier on the slope of the thin-layer chromatographic equation. J. Chromatogr. A, 669, 246-253.
25. Biagi, G.L., Barbaro, A.M. and Recanatini, M. (1994c) Determination of lipophilicity by means of reversed-phase thin-layer chromatography. iii. Study of the TLC equations for a series of ionizable quinolone derivatives. J. Chromatogr. A, 678, 127-137.
26. Bird, A.E. and Marshall, C. (1971) Reversed-phase thin layer chromatography and partition coefficients of penicillins. J. Chromatogr. A, 63, 313-319.
27. Chiou, C.T., Schmedding, D.W. and Manes, M. (1982) Partitioning of organic compounds in octanol-water systems. Environ. Sci. Technol., 16, 4-10.
28. Jack, D.B., Hawker, J.L., Rooney, L. et al. (1988) Measurement of the distribution coefficients of several classes of drug using reversed-phase thin-layer chromatography. J. Chromatogr. A, 452, 257-264.
29. Komsta, L., Skibinski, R., Berecka, A. et al. (2010) Revisiting thin-layer chromatography as a lipophilicity determination tool - a comparative study on several techniques with a model solute set. J. Pharm. Biomed. Anal., 53, 911-918.
30. Lambert, W.J. (1993) Modeling oil-water partitioning and membrane permeation using reversed-phase chromatography. J. Chromatogr. A, 656, 469-484.
31. Leo, A., Hansch, C. and Elkins, D. (1971) Partition coefficients and their uses. Chem. Rev., 71, 525-616.
32. Valkó, K. (1984) General approach for the estimation of octanol/water partition coefficient by reversed-phase high-performance liquid chromatography. J. Liq. Chromatogr., 7, 1405-1424.
33. Valkó, K. (2004) Application of high-performance liquid chromatography based measurements of lipophilicity to model biological distribution. J. Chromatogr. A, 1037, 299-310.
34. Valkó, K. and Slégel, P. (1993) New chromatographic hydrophobicity index (φ0) based on the slope and the intercept of the log K _ versus organic phase concentration plot. J. Chromatogr. A, 631, 49-61.
35. Valkó, K., Bevan, C. and Reynolds, D. (1997) Chromatographic hydrophobicity index by fast-gradient RP-HPLC: a high-throughput alternative to log P/log D. Anal. Chem., 69, 2022-2029.
36. Weber Jr, W.J., Chin, Y.-P. and Rice, C.P. (1986) Determination of partition coefficients and aqueous solubilities by reverse phase chromatography - I. Theory and background. Water Res., 20, 1433-1442.
37. Wells, J.I. (1988) Pharmaceutical Preformulation. The Physicochemical Properties of Drug Substances, John Wiley & Sons, Ltd, Chichester. ISBN 0-470-21114-8.
38. ASTM standard E928-08 (2008) Standard test method for determination of purity by differential scanning calorimetry. ASTM International, West Conshohocken, PA. DOI:10.1520/E0928-08.
39. Amidon, G.L., Lennernäs, H., Shah, V.P. and Crison, J.R. (1995) A theoretical basis for a biopharmaceutical drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res., 12, 413-420.
40. Granberg, R.A. and Rasmuson, A.C. (1999) Solubility of paracetamol in pure solvents. J. Chem. Engng Data, 44, 1391-1395.
41. Kaplan, S.A. (1972) Biopharmaceutical considerations in drug formulation design and evaluation. Drug Met. Rev., 1, 15-34.
42. Kennedy, T. (1997) Managing the drug discovery/development interface. Drug Disc. Today, 2, 436-444.
43. Marti, E.E. (1972) Purity determination by differential scanning calorimetry. Thermochim. Acta, 5, 173-220.
44. Mota, F.L., Carneiro, A.P., Queimada, A.J. et al. (2009) Temperature and solvent effects in the solubility of some pharmaceutical compounds: measurements and modeling. Eur. J. Pharm. Sci., 37, 499-507.
45. Prankerd, R.J. (1992) Solid state properties of drugs. I. Estimation of heat capacities for fusion and thermodynamic functions for solution from aqueous solubility-temperature dependence measurements. Int. J. Pharm., 84, 233-244.
46. Sato, T., Okada, A., Sekiguchi, K. and Tsuda, Y. (1981) Difference in physic-chemical properties between crystalline and non-crystalline 9,3__-diacetylmidecamycin. Chem. Pharm. Bull., 29, 2675-2682.
47. Sondack, D.L. (1972) Simple equation for linearization of data in differential scanning calorimetric purity determinations. Anal. Chem., 44, 888.
48. Stegemann, S., Leveiller, F., Franchi, D. et al. (2007) When poor solubility becomes an issue: from early stage to proof of concept. Eur. J. Pharm. Sci., 31, 249-261.
49. Tsume, Y. and Amidon, G.L. (2010) The biowaiver extension for BCS class III drugs: the effect of dissolution rate on the bioequivalence of BCS class III immediate-release drugs predicted by computer simulation. Molec. Pharm., 7, 1235-1243.
50. van Dooren, A.A. and Müller, B.W. (1984) Purity determinations of drugs with differential scanning calorimetry (DSC) - a critical review. Int. J. Pharm., 20, 217-233.
51. Wells, J.I. (1988) Pharmaceutical Preformulation. The Physicochemical Properties of Drug Substances, John Wiley & Sons, Ltd, Chichester. ISBN 0-470-21114-8.
52. Brunner, E. (1904) Reaktionsgeschwindigkeit in heterogenen systemen. Z. Phys. Chem., 43, 56-102.
53. Brunner, E. and Tolloczko, S. (1900) Über die Auflösungsgeschwindigkeit fester Körper. Z. Phys. Chem., 35, 283-290.
54. Danckwerts, P.V. (1951) Significance of liquid-film coefficients in gas absorption. Ind. Engng Chem., 43, 1460-1467.
55. Dokoumetzidis, A. and Macheras, P. (2006)Acentury of dissolution research: from Noyes and Whitney to the biopharmaceutical classification system. Int. J. Pharm., 321, 1-11.
56. Dressman, J.B. and Reppas, C. (2000) In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs. Eur. J. Pharm. Sci., 11, S73-S80.
57. Klein, S. (2006) The mini paddle apparatus - a useful tool in the early developmental stage? Experiences with immediate-release dosage forms. Dissol. Technol., 13, 6-11.
58. Li, S., Doyle, P., Metz, S. et al. (2005) Effect of chloride ion on dissolution of different salt forms of haloperidol, a model basic drug. J. Pharm. Sci., 94, 2224-2231.
59. Lindahl, A., Ungell, A.L. and Lennernas, H. (1997) Characterization of fluids from the stomach and proximal jejunum in men and women. Pharm. Res., 14, 497-502.
60. McConnell, E.L. Fadda, H.M. and Basit, A.W. (2008) Gut instincts: explorations in intestinal physiology and drug delivery. Int. J. Pharm., 364, 213-226.
61. Nernst, W. (1904) Theorie der Reaktionsgeschwindigkeit in Heterogenen Systemen. Z. Phys. Chem., 47, 52-55.
62. Noyes, A.A. and Whitney, W.R. (1897) The rate of solution of solid substances in their own solutions. J. Am. Chem. Soc., 19, 930-934.
63. Schiller, C., Fröhlich, C.-P., Giessmann, T. et al. (2005) Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging. Ailment Pharmacol. Theory, 22, 971-979.
64. Serajuddin, A.T.M. and Jarowski, C.I. (1985) Effect of diffusion layer pH and solubility on the dissolution rate of pharmaceutical acids and their sodium salts. II: salicylic acid, theophylline and benzoic acid. J. Pharm. Sci., 74, 148-154.
65. Viegas, T.X., Curatella, R.U., Van Winkle, L.L. and Brinker, G. (2001) Measurement of intrinsic drug dissolution using two types of apparatus. Pharm Technol., 25, 44-43.
66. Wilderman, M. (1909) Über die Geschwindigkeit Molekularer und Chemischer Reaktionen in Heterogenen Systemen. Erster Teil. Z. Phys. Chem., 66, 445-495.
67. Bandura, A.V. and Lvov, S.N. (2005) The ionization constant of water over wide ranges of temperature and density. J. Phys. Chem. Ref. Data, 35, 15-30.
68. Berge, S.M., Bighley, L.D. and Monkhouse, D.C. (1977) Pharmaceutical salts. J. Pharm. Sci., 66, 1-19.
69. Bhogala, B.R., Basavoju, S. and Nangia, A. (2005) Tape and layer structures in cocrystals of some di- and tricarboxylic acids with 4,4_-bipyridines and isonicotinamide. From binary to ternary cocrystals. Crys. Engng Commun., 7, 551-562.
70. Bogardus, J.B. and Blackwood, R.K. (1979) Solubility of doxycycline in aqueous solution. J. Pharm. Sci., 68, 188-194.
71. Brittain, H.G. (2007) Strategy for the prediction and selection of drug substance salt forms. Pharm. Technol., 31, 78-88.
72. Brittain, H.G. (2008) Introduction and overview to the preformulation development of solid dosage forms. In Preformulation in Solid Dosage Form Development (eds M.C. Adeyeye and H.G. Brittain), Informa Healthcare, New York. ISBN 0-8247-5809-9.
73. Childs, S.L., Stahly, G.P. and Park, A. (2007) The salt-cocrystal continuum: the influence of crystal structure on ionization state. Molec. Pharm., 4, 323-338.
74. Cui, N., Friend, D.R. and Fedorak, R.N. (1994) A budesonide prodrug accelerates treatment of colitis in rats. Gut, 35, 1439-1446.
75. Doh, M.J., Jung, Y.J., Kim, I.H. et al. (2003) Synthesis and in vitro properties of prednisolone 21-sulfate sodium as a colon-specific prodrug of prednisolone. Arch. Pharm. Res., 26, 258-263.
76. Doherty, C. and York, P. (1989) Microenvironmental pH control of drug dissolution. Int. J. Pharm., 50, 223-232.
77. Espinoza, R., Hong, E. and Villafuerte, L. (2000) Influence of admixed citric acid on the release profile of pelanserin hydrochloride from HPMC matrix tablets. Int. J. Pharm., 201, 165-173.
78. Fini, A., Fazio, G., Fernández Hervás, M.-J. et al. (1996) Factors affecting the dissolution of diclofenac salts. Eur. J. Pharm. Sci., 4, 231-238.
79. Govindarajan, R., Zinchuk, A., Hancock, B. et al. (2006) Ionization states in the microenvironment of solid dosage forms: effect of formulation variables and processing. Pharm. Res., 23, 2454-2468.
80. Guerrieri, P., Jarring, K. and Taylor, L.S. (2010) Impact of counterion on the chemical stability of crystalline salts of procaine. J. Pharm. Sci., 99, 3719-3730.
81. Haeberlin, B., Rubas, W., Nolen, H.W. and Friend, D.R. (1993) In-vitro evaluation of dexamethasone-beta-D-glucuronide for colon-specific drug-delivery. Pharm. Res., 10, 1553-1562.
82. Heading, R.C., Nimmo, J., Prescott, L.F. and Tothill, P. (1973) The dependence of paracetamol absorption on the rate of gastric emptying. Br. J. Pharmac., 47, 415-421.
83. Huang, L.-F. and Tong, W.-Q. (2004) Impact of solid state properties on developability assessment of drug candidates. Adv. Drug. Del. Rev., 56, 321-334.
84. ICH Guideline Q3C(R5) (2011) Impurities: Guideline for Residual Solvents.
85. Klotz, U. (1985) Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs for 5-aminosalicylic acid. Clin. Pharmacokinet., 10, 285-302.
86. Kramer, S.F. and Flynn, G.L. (1972) Solubility of organic hydrochlorides. J. Pharm. Sci., 61, 1896-1904.
87. Kumar, L., Amin, A. and Bansal, A.K. (2008) Salt selection in drug development. Pharm. Technol., 32 (3), 128-142.
88. Lemke, T.L., Williams, D.A., Roche, V.F. and Zito, S.W. (eds) (2008) Foye's Principles of Medicinal Chemistry, 6th edn, Lippincott, Williams and Wilkins, Baltimore, MD. ISBN 978-0-7817-6879-5.
89. Li, S.F., He, H.D., Parthiban, L.J. et al. (2005a) IV-IVC considerations in the development of immediate-release oral dosage form. J. Pharm. Sci., 94, 1396-1417.
90. Li, S., Wong, S.M., Sethia, S. et al. (2005b) Investigation of solubility and dissolution of a free base and two different salt forms as a function of pH. Pharm. Res., 22, 628-635.
91. Maitani, Y., Kugo, M. and Nagai, T. (1994) Permeation of diclofenac salts through silicone membrane - a mechanistic study of percutaneous-absorption of ionizable drugs. Chem. Pharm. Bull., 42, 1297-1301.
92. Morris, K.R., Fakes, M.G., Thakur, A.B. et al. (1994) An integrated approach to the selection of optimal salt form for a new drug candidate. Int. J. Pharm., 105, 209-217.
93. Nelson, E. (1957) Solution rate of theophylline salts and effects from oral administration. J. Am. Pharm. Soc. Sci. Ed., 46, 607-614.
94. Nie, S., Pan, W., Li, X. and Wu, X. (2004) The effect of citric acid added to hydroxypropyl methylcellulose (HPMC) matrix tablets on the release of vinpocetine. Drug Dev. Ind. Pharm., 30, 627-635.
95. Patel, A., Jones, S.A., Ferro, A. and Patel, N. (2009) Pharmaceutical salts: a formulation trick or a clinical conundrum? Br. J. Cardiol., 16, 281-286.
96. Pudipeddi, M., Serajuddin, A.T.M., Grant, D.J.W. and Stahl, P.H. (2011) Solubility and dissolution of weak acids, bases and salts. In Handbook of Pharmaceutical Salts. Properties, Selection and Use (eds P.H. Stahl and C.G. Wermuth), revised 2nd edn, Wiley-VCH. ISBN 3-906-39051-9.
97. Remenar, J.F., MacPhee, J.M., Larson, B.K. et al. (2003) Salt selection and simultaneous polymorphism assessment via high-throughput crystallization. The case of sertraline. Org. Proc. Res. Dev., 7, 990-996.
98. Rohrs, B.R., Thamann, T.J., Gao, P. et al. (1999) Tablet dissolution affected by a moisture mediated solid-state interaction between drug and disintegrant. Pharm. Res., 16, 1850-1856.
99. Russell, T.L., Berardi, R.R., Barnett, J.L. et al. (1994) pH related changes in the absorption of dipyridamole in the elderly. Pharm. Res., 11, 136-143.
100. Sarveiya, V., Templeton, J.F. and Benson, H.A.E. (2004) Ion-pairs of ibuprofen: increased membrane diffusion. J. Pharm. Pharmacol., 56, 717-724.
101. Serajuddin, A.T.M. (2007) Salt formation to improve drug solubility. Adv. Drug Del. Rev., 59, 603-616.
102. Serajuddin, A.T.M. and Jarowski, C.I. (1985) Effect of diffusion layer pH and solubility on the dissolution rate of pharmaceutical acids and their sodium salts. II: salicylic acid, theophylline and benzoic acid. J. Pharm. Sci., 74, 148-154.
103. Siepe, S., Lueckel, B., Kramer, A. et al. (2006) Strategies for the design of hydrophilic matrix tablets with controlled microenvironmental pH. Int. J. Pharm., 316, 14-20.
104. Stahl, P.H. and Wermuth, C.G. (eds) (2011) Handbook of Pharmaceutical Salts. Properties, Selection and Use, revised 2nd edn, Wiley-VCH. ISBN 3-906-39051-9.
105. Stephenson, G.A., Aburub, A. and Woods, T.A. (2011) Physical stability of weak bases in the solid-state. J. Pharm. Sci., 100, 1607-1617.
106. Streubel, A., Siepmann, J., Dashevsky, A. and Bodmeier, R. (2000) pH-independent release of a weakly basic drug from water-insoluble and -soluble matrix tablets. J. Cont. Rel., 67, 101-110.
107. Tarsa, P.B., Towler, C.S., Woollam, G. and Berghausen, J. (2010) The influence of aqueous content in small scale salt screening - improving hit rate for weakly basic, low solubility drugs. Eur. J. Pharm. Sci., 41, 23-30.
108. Teraoka, R., Otsuka, M. and Matsuda, Y. (1993) Effects of temperature and relative humidity on the solid-state chemical stability of ranitidine hydrochloride. J. Pharm. Sci., 82 (1993) 601-604.
109. Tran, P.H.L., Thanh, H.T. and Lee, B.-J. (2008) Modulation of microenvironmental pH and crystallinity of ionizable telmisartan using alkalizers in solid dispersions for controlled release. J. Cont. Rel., 129, 59-65.
110. Varma, M.V.S., Kaushal, A.M. and Garg, S. (2005) Influence of micro-environmental pH on the gel layer and release of a basic drug from various hydrophilic matrices. J. Cont. Rel., 103, 499-510.
111. Wells, J.I. (1988) Pharmaceutical Preformulation. The Physicochemical Properties of Drug Substances. John Wiley & Sons, Ltd, Chichester. ISBN 0-470-21114-8.
112. Yamada, I., Goda, T., Kawata, M. and Ogawa, K. (1990) Application of gastric aciditycontrolled beagle dog to bioavailability study of cinnarizine. Yakugaku Zasshi, 110, 280-285.
113. Zannou, E.A., Yatindra, Q.J., Joshi, M. and Serajuddin, A.T.M. (2007) Stabilization of the maleate salt of a basic drug by adjustment of microenvironment pH in solid dosage form. Int. J. Pharm., 337, 210-218.
114. Aguiar, A.J., Krc Jr, J., Kinkel, A.W. and Samyn, J.C. (1967) Effect of polymorphism on the absorption of chloramphenicol from chloramphenicol palmitate. J. Pharm. Sci., 56, 847-853.
115. Bravais, A. (1850)Mémoire sur les syst 'emes form' es par les points distribués régulièrement sur un plan ou dans l'espace. J. Ecole Polytech., 19, 1-128.
116. Gaisford, S., Buanz, A.B.M. and Jethwa, N. (2010) Characterisation of paracetamol Form III with rapid-heating DSC. J. Pharm. Biomed. Anal., 53, 366-370.
117. Glicksman, M.E. (2011) Principles of Solidification. An Introduction to Modern Casting and Crystal Growth Concepts, Springer. ISBN 978-1-4419-7343-6.
118. Grant, D.J.W. (1999) Theory and origin of polymorphism. In Polymorphism in Pharmaceutical Solids (ed. H.G. Brittain), Informa Healthcare. ISBN 0-8247-0237-3.
119. Lohani, S. and Grant, D.J.W. (2006) Thermodynamics of polymorphs. In Polymorphism in the Pharmaceutical Industry (ed. R. Hilfiker), Wiley-VCH. ISBN 3-5273-1146-7.
120. McGregor, C. and Bines, E. (2008) The use of high-speed differential scanning calorimetry (Hyper-DSC) in the study of pharmaceutical polymorphs. Int. J. Pharm., 350, 48-52.
121. McGregor, C., Saunders, M. and Buckton, G. (2004) The use of high-speed differential scanning calorimetry (DSC) to study the thermal properties of carbamazepine polymorphs. Thermochim. Acta, 417, 231-237.
122. Mullin, J.W. (2001) Crystallization, 4th edn, Butterworth-Heinemann, Oxford. ISBN 0-7506-4833-3.
123. Schinzer, W.C., Bergren, M.S. and Aldrich, D.S. (1997) Characterization and interconversion of polymorphs of premafloxacin, a new quinolone antibiotic. J. Pharm. Sci., 86, 1426-1431.
124. Brodka-Pfeiffer, K., Langguth, P., Graß, P. and Häusler, H. (2003) Influence of mechanical activation on the physical stability of salbutamol sulphate. Eur. J. Pharm. Biopharm., 56, 393-400.
125. Chen, X., Bates, S. and Morris, K.R. (2001) Quantifying amorphous content of lactose using parallel beam X-ray powder diffraction and whole pattern fitting. J. Pharm. Biomed. Anal., 26, 63-72.
126. Giron, D., Monnier, S., Mutz, M. et al. (2007) Comparison of quantitative methods for analysis of polyphasic pharmaceuticals. J. Therm. Anal. Cal., 89, 729-743.
127. Guinot, S. and Leveiller, F. (1999) The use of MTDSC to assess the amorphous phase content of a micronised drug substance. Int. J. Pharm., 192, 63-75.
128. Hancock, B.C. (1998) Comments on 'An approach to estimate the amorphous content of pharmaceutical powders using calorimetry with no calibration standards'. Int. J. Pharm., 160, 131-133.
129. Hogan, S.E. and Buckton, G. (2000) The quantification of small degrees of disorder in lactose using solution calorimetry. Int. J. Pharm., 207, 57-64.
130. Kawakami, K. and Pikal, M.J. (2005) Calorimetric investigation of the structural relaxation of amorphous materials: evaluating validity of the methodologies. J. Pharm. Sci., 94, 948-965.
131. Lappalainen, M., Pitkänen, I. and Harjunen, K. (2006) Quantification of low levels of amorphous content in sucrose by hyperDSC. Int. J. Pharm., 307, 150-155.
132. Mackin, L., Zanon, R., Park, J.M. et al. (2002) Quantification of low levels (<10%) of amorphous content in micronised active batches using dynamic vapour sorption and isothermal microcalorimetry. Int. J. Pharm., 231, 227-236.
133. Newell, H.E., Buckton, G., Butler, D.A. et al. (2001) The use of inverse phase gas chromatography to measure the surface energy of crystalline, amorphous and recently milled lactose. Pharm. Res., 18, 662-666.
134. O'Neill, M.A.A. and Gaisford, S. (2011) Application and use of isothermal calorimetry in pharmaceutical development. Int. J. Pharm., 417, 83-93.
135. K. J. Non-Cryst. Solids, 172-174, 93-103.
136. Phillips, E.M. (1997) An approach to estimate the amorphous content of pharmaceutical powders using calorimetry with no calibration standards. Int. J. Pharm., 149, 267-271.
137. Ramos, R., Gaisford, S. and Buckton, G. (2005) Calorimetric determination of amorphous content in lactose: a note on the preparation of calibration curves. Int. J. Pharm., 300, 13-21.
138. Saklatvala, R., Royall, P.G. and Craig, D.Q.M. (1999) The detection of amorphous material in a nominally crystalline drug using modulated temperature DSC - a case study. Int. J. Pharm., 192, 55-62.
139. Saunders, M., Podluii, K., Shergill, S. et al. (2004) The potential of high speed DSC (hyper-DSC) for the detection and quantification of small amounts of amorphous content in predominantly crystalline samples. Int. J. Pharm., 274, 35-40.
140. Vollenbroek, J., Hebbink, G.A., Ziffels, S. and Steckel, H. (2010) Determination of low levels of amorphous content in inhalation grade lactose by moisture sorption isotherms. Int. J. Pharm., 395, 62-70.
141. Williams, G. and Watts, D.C. (1970) Non-symmetrical dielectric relaxation behaviour arising from a simple empirical decay function. Trans. Fara. Soc., 66, 80-85.
142. Connors, K.A., Amidon, G.L. and Stella, V.J. (1986) Chemical Stability of Pharmaceuticals, 2nd edn, John Wiley & Sons, Ltd. ISBN 0-4718-8795-X.
143. Day, J.N.E. and Ingold, C.K. (1941) Mechanism and kinetics of carboxylic ester hydrolysis and carboxyl esterification. Trans. Faraday Soc., 37, 686-705.
144. Fryklöf, L.-E. (1954) Autoxidation of etheric oils used in pharmacy. Farm. Rev., 53, 317-335.
145. Greenspan, L. (1977) Humidity fixed of binary saturated aqueous solutions. J. Res. Natl Bur. Stand., 81A (1977) 89-96.
146. Grimm, W. (1986) Storage conditions for stability testing (Part 2). Drugs Made in Germany, 29, 39-47.
147. Grimm, W. (1998) Extension of the International Conference on Harmonisation Tripartite Guidelines for stability testing of new drug substances and products to countries of Climatic Zones III and IV. Drug Dev. Ind. Pharm., 24, 313-325.
148. ICH Harmonised Tripartite Guideline Q1A(R2) (2003) Stability testing of new drug substances and products.
149. ICH Harmonised Tripartite Guideline Q1B (1996) Stability testing: photostability testing of new drug substances and products.
150. Ingold, C.K. (1953) Structure and Mechanism in Organic Chemistry, Cornell University Press. ISBN 0-8014-0499-1.
151. ISO 10977 (1993) Photography. Processed photographic colour films and paper prints -methods for measuring image stability.
152. Kommanaboyina, B. and Rhodes, C.T. (1999) Trends in stability testing, with emphasis on stability during distribution and storage. Drug. Dev. Ind. Pharm., 25, 857-868.
153. Kondrat'eva, A.P., Bruns, B.P. and Libinson, G.S. (1971) Stability of d-cycloserine in aqueous solutions at high concentrations. Pharm. Chem. J., 5, 356-360.
154. Loucas, S.P., Mehl, B., Litwak, R.S. and Jurado, R.A. (1981) Stability of procaine hydrochloride in a buffered cardioplegia formulation. Am. J. Hosp. Pharm., 38, 1924-1928.
155. Wells, J.I. (1988) Pharmaceutical Preformulation. The Physicochemical Properties of Drug Substances, John Wiley & Sons, Ltd, Chichester. ISBN 0-470-21114-8.
156. Banga, S., Chawla, G., Varandani, D. and Mehta, B.R. (2007) Modification of the crystal habit of celecoxib for improved processability. J. Pharm. Pharmacol., 59, 29-39.
157. Brittain, H.G. (2001) Particle size distribution, Part 1, representations of particle shape, size and distribution. Pharm. Technol., 25, 38-45.
158. Kaul, D., Nguyen, N.T. and Venkataram, S. (1992) Crystal habit modifications and altered tableting characteristics. Int. J. Pharm., 88, 345-350.
159. Rasenack, N. andMüller, B.W. (2002) Crystal habit and tableting behavior. Int. J. Pharm., 244, 45-57.
160. Carr, R.L. (1965) Evaluating flow properties of solids. Chem. Engng, 72, 163-167.
161. Hausner, H.H. (1967) Friction conditions in a mass of metal powder. Int. J. Powder Metall., 3, 7-13.
162. Jones, T.M. and Pilpel, N. (1966) Some angular properties of magnesia and their relevance to material handling. J. Pharm. Pharmacol., 18, 182T.
163. Schulze, D. (2008) Powders and Bulk Solids. Behaviour, Characterisation, Storage and Flow, Springer, Berlin. ISBN 978-3-540-73767-4.
164. Sebhatu, T., Elamin, A.A. and Ahlneck, C. (1994) Effect of moisture sorption on tableting characteristics of spray dried (15% amorphous) lactose. Pharm. Res., 11, 1233-1238.
165. Wells, J.I. (1988) Pharmaceutical Preformulation. The Physicochemical Properties of Drug Substances, John Wiley & Sons, Ltd, Chichester. ISBN 0-470-21114-8.